pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3679 |
Genomic Coordinates | chr2: 134127125 - 134127192 |
Description | Homo sapiens miR-3679 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3679-5p | |||||||||||||||
Sequence | 6| UGAGGAUAUGGCAGGGAAGGGGA |28 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | EPHA2 | ||||||||||||||||||||
Synonyms | ARCC2, CTPA, CTPP1, CTRCT6, ECK | ||||||||||||||||||||
Description | EPH receptor A2 | ||||||||||||||||||||
Transcript | NM_004431 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on EPHA2 | |||||||||||||||||||||
3'UTR of EPHA2 (miRNA target sites are highlighted) |
>EPHA2|NM_004431|3'UTR 1 GCCTCGACAGGGCCTGGAGCCCCATCGGCCAAGAATACTTGAAGAAACAGAGTGGCCTCCCTGCTGTGCCATGCTGGGCC 81 ACTGGGGACTTTATTTATTTCTAGTTCTTTCCTCCCCCTGCAACTTCCGCTGAGGGGTCTCGGATGACACCCTGGCCTGA 161 ACTGAGGAGATGACCAGGGATGCTGGGCTGGGCCCTCTTTCCCTGCGAGACGCACACAGCTGAGCACTTAGCAGGCACCG 241 CCACGTCCCAGCATCCCTGGAGCAGGAGCCCCGCCACAGCCTTCGGACAGACATATGGGATATTCCCAAGCCGACCTTCC 321 CTCCGCCTTCTCCCACATGAGGCCATCTCAGGAGATGGAGGGCTTGGCCCAGCGCCAAGTAAACAGGGTACCTCAAGCCC 401 CATTTCCTCACACTAAGAGGGCAGACTGTGAACTTGACTGGGTGAGACCCAAAGCGGTCCCTGTCCCTCTAGTGCCTTCT 481 TTAGACCCTCGGGCCCCATCCTCATCCCTGACTGGCCAAACCCTTGCTTTCCTGGGCCTTTGCAAGATGCTTGGTTGTGT 561 TGAGGTTTTTAAATATATATTTTGTACTTTGTGGAGAGAATGTGTGTGTGTGGCAGGGGGCCCCGCCAGGGCTGGGGACA 641 GAGGGTGTCAAACATTCGTGAGCTGGGGACTCAGGGACCGGTGCTGCAGGAGTGTCCTGCCCATGCCCCAGTCGGCCCCA 721 TCTCTCATCCTTTTGGATAAGTTTCTATTCTGTCAGTGTTAAAGATTTTGTTTTGTTGGACATTTTTTTCGAATCTTAAT 801 TTATTATTTTTTTTATATTTATTGTTAGAAAATGACTTATTTCTGCTCTGGAATAAAGTTGCAGATGATTCAAACCGAAA 881 AAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11
PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177617. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_7
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177629. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_7
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000358432.5 | 3UTR | UUCUUUAGACCCUCGGGCCCCAUCCUCAUCCCUGACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
55 hsa-miR-3679-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT114494 | PNN | pinin, desmosome associated protein | 2 | 2 | ||||||||
MIRT169967 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 6 | ||||||||
MIRT182181 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT189380 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT364735 | TOR1B | torsin family 1 member B | 2 | 2 | ||||||||
MIRT445477 | KDM6A | lysine demethylase 6A | 2 | 2 | ||||||||
MIRT446333 | ATP5C1 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 | 2 | 2 | ||||||||
MIRT446386 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT446971 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT449793 | C1orf109 | chromosome 1 open reading frame 109 | 2 | 2 | ||||||||
MIRT451211 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 2 | 2 | ||||||||
MIRT452098 | NUCB2 | nucleobindin 2 | 2 | 2 | ||||||||
MIRT454036 | DDT | D-dopachrome tautomerase | 2 | 2 | ||||||||
MIRT461708 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT464957 | TWIST1 | twist family bHLH transcription factor 1 | 2 | 2 | ||||||||
MIRT465775 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT466925 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT471388 | PDPR | pyruvate dehydrogenase phosphatase regulatory subunit | 2 | 2 | ||||||||
MIRT473585 | MAT2A | methionine adenosyltransferase 2A | 2 | 2 | ||||||||
MIRT476070 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | 2 | 2 | ||||||||
MIRT477324 | EPHA2 | EPH receptor A2 | 2 | 2 | ||||||||
MIRT478244 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 4 | ||||||||
MIRT480449 | C16orf72 | chromosome 16 open reading frame 72 | 2 | 6 | ||||||||
MIRT481866 | ANKRD50 | ankyrin repeat domain 50 | 2 | 2 | ||||||||
MIRT492032 | TSG101 | tumor susceptibility 101 | 2 | 4 | ||||||||
MIRT493737 | GRAP2 | GRB2-related adaptor protein 2 | 2 | 2 | ||||||||
MIRT495623 | PPP1R1C | protein phosphatase 1 regulatory inhibitor subunit 1C | 2 | 2 | ||||||||
MIRT497590 | SLC23A1 | solute carrier family 23 member 1 | 2 | 2 | ||||||||
MIRT504702 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT507794 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT510653 | TMED7 | transmembrane p24 trafficking protein 7 | 2 | 4 | ||||||||
MIRT525534 | FSIP2 | fibrous sheath interacting protein 2 | 2 | 2 | ||||||||
MIRT531149 | CYGB | cytoglobin | 2 | 2 | ||||||||
MIRT536003 | MED13 | mediator complex subunit 13 | 2 | 2 | ||||||||
MIRT537056 | GPR180 | G protein-coupled receptor 180 | 2 | 2 | ||||||||
MIRT538297 | CSNK2A1 | casein kinase 2 alpha 1 | 2 | 2 | ||||||||
MIRT544755 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT544927 | MIS18BP1 | MIS18 binding protein 1 | 2 | 2 | ||||||||
MIRT556973 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT561714 | PPP2R2A | protein phosphatase 2 regulatory subunit Balpha | 2 | 2 | ||||||||
MIRT563632 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT564705 | ZNF322P1 | zinc finger protein 322 pseudogene 1 | 2 | 2 | ||||||||
MIRT572190 | CALU | calumenin | 2 | 2 | ||||||||
MIRT573900 | MKI67 | marker of proliferation Ki-67 | 2 | 2 | ||||||||
MIRT576073 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576150 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT614848 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 4 | ||||||||
MIRT647592 | FAM109B | family with sequence similarity 109 member B | 2 | 2 | ||||||||
MIRT657009 | KCNMB4 | potassium calcium-activated channel subfamily M regulatory beta subunit 4 | 2 | 2 | ||||||||
MIRT691268 | GET4 | golgi to ER traffic protein 4 | 2 | 2 | ||||||||
MIRT695778 | DENR | density regulated re-initiation and release factor | 2 | 2 | ||||||||
MIRT698089 | TPM1 | tropomyosin 1 | 2 | 2 | ||||||||
MIRT732571 | IGLL5 | immunoglobulin lambda like polypeptide 5 | 1 | 0 | ||||||||
MIRT733722 | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase | 3 | 0 | ||||||||
MIRT734354 | GREM1 | gremlin 1, DAN family BMP antagonist | 1 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|